MentionFox
Home › Executive changes › Drugs Made In America Acquisition II Corp.
Leadership changes · DMII · SEC Form 8-K, Item 5.02

Leadership changes at Drugs Made In America Acquisition II Corp. (2026)

Before you join, sell to or invest in Drugs Made In America Acquisition II Corp.

MentionFox check on Drugs Made In America Acquisition II Corp.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/drugs-made-in-america-acquisition-ii

Check Drugs Made In America Acquisition II Corp. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Drugs Made In America Acquisition II Corp.?

Who joined and who left Drugs Made In America Acquisition II Corp. (DMII)? 1 appointment reported on 2026-03-06, each cited to the company's own filing.

Roger Bendelac was named Chief Executive Officer of Drugs Made In America Acquisition II Corp. As of November 14, 2026, Drugs Made In America Acquisition II Corp. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 6, 2026, naming 1 appointment (Form 8-K, March 6, 2026).

29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

KARPUS MANAGEMENT, INC. also filed stake reports on 96 other companies ↓

Sell to companies like Drugs Made In America Acquisition II Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
In (appointed)1
Latest filing2026-03-06

Drugs Made In America Acquisition II Corp. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-06. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Drugs Made In America Acquisition II Corp. files it.

Also on the record for Drugs Made In America Acquisition II Corp.

DateRecordFigureOur pageSource
November 13, 2026Stake report, Schedule 13G, by KARPUS MANAGEMENT, INC.5.18% of the class5%+ stakesSource
October 2, 2025Stake report, Schedule 13D, by Drugs Made In America Acquisition II LLC10.2% of the class5%+ stakesSource
September 25, 2025IPO filing, Form 424B4$10 a shareIPO filingsSource
September 16, 2025IPO filing, Form S-1/A—IPO filingsSource
September 15, 2025IPO filing, Form S-1/A—IPO filingsSource
September 5, 2025IPO filing, Form S-1/A—IPO filingsSource
July 21, 2025IPO filing, Form S-1—IPO filingsSource

Selling to them or working with them? See who runs Drugs Made In America Acquisition II Corp. now and the warning signs.

Watch Drugs Made In America Acquisition II Corp.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Drugs Made In America Acquisition II Corp. and the records around it.

Drugs Made In America Acquisition II Corp. elsewhere on the record

Companies that share a holder

Want the whole picture on Drugs Made In America Acquisition II Corp.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Drugs Made In America Acquisition II Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Drugs Made In America Acquisition II Corp. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    8 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-03-06InChief Executive Officer8-K, 2026-03-06

Who leads Drugs Made In America Acquisition II Corp., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Drugs Made In America Acquisition II Corp.?

New leaders reset buying decisions — get the Full Report on Drugs Made In America Acquisition II Corp.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Drugs Made In America Acquisition II Corp.

Hiring for a seat like this?

Find people with the same kind of experience as the Chief Executive Officer at Drugs Made In America Acquisition II Corp., with the record behind each one.

Find candidates like Chief Executive Officer at Drugs Made In America Acquisition II Corp.

Every change, in the filing's words

Filed 2026-03-06 · 8-K

Appointed: Roger Bendelac, Chief Executive Officer

On February 28, 2026, Roger Bendelac was appointed to the position of Chief Executive Officer of the Company to be effective as of the date of Ms. Stockwell's resignation as the Company's Chief Executive Officer.

Also stated in this filing

  • Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
  • As previously reported in the Quarterly Report on Form 10-Q for the period ended September 30, 2025, for Drugs Made In America Acquisition II Corp. (the "Company"), between the completion of the Company's initial public offering on September 26, 2025 and September 30, 2025, the sponsor to the Company (the "Sponsor") withdrew an aggregate amount of $1,100,000 (the "Withdrawal") from the Company's working capital account (the "Account").
  • Of the aggregate Withdrawal amount, $325,000 was used to repay an outstanding working capital note (the "Note") to the Sponsor and $208,000 was used to repay other offering costs and expenses to the Sponsor, which amounts, in aggregate, were above the amounts previously advanced by the sponsor to the Company under the Note.
  • An additional amount of $566,269 also appeared as an overpayment to the Sponsor by the Company and between September 30, 2025 and December 31, 2025, the Sponsor withdrew additional funds from the Account, in an amount no less than $200,000 to pay for expenses unrelated to the Company (the "Overpayment Amount").

Tools for this story

Each opens in a new tab, filled in for Drugs Made In America Acquisition II Corp.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/drugs-made-in-america-acquisition-ii
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who joined Drugs Made In America Acquisition II Corp.?. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/drugs-made-in-america-acquisition-ii